icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Successful Treatment with Direct Acting Antivirals in HIV/HCV
Patients ....95% SVR with Sim/Sof in real-world clinic setting/support services
 
 
  "......SVR12 rates in our cohort of HIV/HCV patients on SOF+SMV (95%) were comparable to those observed in the COSMOS trial although slightly higher than those reported in recent 'real world' studies (TRIO (89%) and HCV-TARGET (82%)). Closer monitoring of a dually infected population and a multi-disciplinary approach to treatment may account for our higher success rates."
 
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
 
Jennifer Grant1; Valentina Stosor1; Frank Palella1; Richard Green2; Guajira Thomas1; Donna McGregor1; Milena McLaughlin3;
Sudhir Penugonda1; Michael Angarone1; Claudia Hawkins1
Divisions of Infectious Diseases1 and Hepatology2, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Midwestern University, Chicago College of Pharmacy3

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif